Equities

Nxera Pharma Co Ltd

Nxera Pharma Co Ltd

Actions
  • Price (EUR)7.10
  • Today's Change0.150 / 2.16%
  • Shares traded--
  • 1 Year change-21.11%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 07:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(10680)1,078433
Depreciation/depletion2,4781,3451,278
Non-Cash items1,8413,5656,711
Cash taxes paid, supplemental1,394262(87)
Cash interest paid, supplemental241171157
Changes in working capital1,0883,964(1327)
Total cash from operations(5273)9,9527,095
INVESTING
Capital expenditures(851)(303)(201)
Other investing and cash flow items, total(62940)1,346479
Total cash from investing(63791)1,043278
FINANCING
Financing cash flow items(27)(4681)(191)
Total cash dividends paid------
Issuance (retirement) of stock, net9,9830600
Issuance (retirement) of debt, net38,373(206)10,714
Total cash from financing48,329(4887)11,123
NET CHANGE IN CASH
Foreign exchange effects3,2433621,583
Net change in cash(17492)6,47020,079
Net cash-begin balance/reserved for future use66,55760,08740,008
Net cash-end balance/reserved for future use49,06566,55760,087
SUPPLEMENTAL INCOME
Depreciation, supplemental2,4781,3451,278
Cash interest paid, supplemental241171157
Cash taxes paid, supplemental1,394262(87)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.